Evidence map›Paper›PMID 39813451›Full record

ArticleEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2025

HIV prevention among adolescents travestis and transgender women in three Brazilian capitals, 2019-2023.

Beo Oliveira Leite, Laio Magno, Dirceu Greco, Alexandre Grangeiro, Ines Dourado

Abstract read
In one paragraph

Article in Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Beo Oliveira LeiteUniversidade Federal da Bahia, Instituto de Saúde Coletiva, Salvador, BA, Brazil.ORCID http://orcid.org/0000-0002-4137-9809
Laio MagnoUniversidade Federal da Bahia, Instituto de Saúde Coletiva, Salvador, BA, Brazil.ORCID http://orcid.org/0000-0003-3752-0782
Dirceu GrecoUniversidade Federal de Minas Gerais, Escola de Medicina, Belo Horizonte, MG, Brazil.ORCID http://orcid.org/0000-0002-4419-5634
Alexandre GrangeiroUniversidade de São Paulo, Departamento de Medicina Preventiva, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-5157-0597
Ines DouradoUniversidade Federal da Bahia, Instituto de Saúde Coletiva, Salvador, BA, Brazil.ORCID http://orcid.org/0000-0003-1675-2146

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe HIV prevention strategies and gender-based discrimination among adolescent travestis and transgender women.

methodsThis was a cross-sectional study involving 148 adolescent travestis and transgender women aged 15 to 19 years in Salvador, Bahia state, São Paulo, São Paulo state, and Belo Horizonte, Minas Gerais state, conducted between February 2019 and March 2023. Fisher's exact test was performed to assess differences between prevention strategies and gender-based discrimination within healthcare services.

results18.9 % reported engaging in receptive anal sex using condom in the past 6 months; 62.2% had undergone HIV test at least once in their lifetime; and 88.5% had started pre-exposure prophylaxis (PrEP) for HIV. Adolescents aged 15 to 17 years with previous experiences of discrimination in healthcare services had undergone fewer HIV tests in their lifetime or had started PrEP less frequently.

conclusionThere is an urgent need for the implementation of public policies that eradicate gender-based discrimination and expand access to HIV prevention.

Indexed as

HIV InfectionsTransgender PersonsAdolescentAdultBrazilCondomsCross-Sectional StudiesFemaleHIV TestingHumansMalePre-Exposure ProphylaxisSexismSexual BehaviorYoung Adult

Identifiers

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.